An Open-Label, Three Period, Single Sequence Study To Determine The Effect Of Repeat Oral Dosing Of Diltiazem On The Pharmacokinetics Of Repeat Oral Dosing Of Darapladib (SB-480848).
Phase of Trial: Phase I
Latest Information Update: 19 May 2017
At a glance
- Drugs Darapladib (Primary) ; Diltiazem
- Indications Angina pectoris; Arrhythmias; Asthma; Atherosclerosis; Diabetic macular oedema; Hypertension
- Focus Pharmacokinetics
- 01 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Jun 2013 Planned number of patients changed from 30 to 36 as reported by ClinicalTrials.gov.